A meta-analysis of phase 3 randomized controlled trials has revealed that combining PD-1/PD-L1 inhibitors with chemotherapy demonstrated greater efficacy than chemotherapy monotherapy in treating advanced cervical cancer (R/M or locally advanced), enhancing both OS and objective response rates (58). The gene discussed is CD274; the disease is cervical cancer.